{
  "id": 1098345,
  "title": "Otter Tail VP, human resources Paul Knutson sells $68,159 in stock",
  "url": "https://urgent.news/2026/08/15/otter-tail-vp-human-resources-paul-knutson-sells-68-159-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-15T18:46:01.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/otter-tail-vp-human-resources-paul-knutson-sells-68159-in-stock-93CH-4861829"
  },
  "original_language": "en",
  "account": "Paul L. Knutson, the Vice President of Human Resources at Otter Tail Corp (NASDAQ:OTTR), recently sold a portion of the company's common stock, amounting to $68,159. This sale took place on two consecutive days, August 10 and August 11, 2026, with share prices fluctuating between $92.84 and $94.63. On August 10, Knutson sold 250 shares at $92.84 per share, while on August 11, he disposed of an additional 475 shares at the higher price of $94.63 per share. Both transactions involved direct holdings of the stock. It is worth noting that the stock is currently trading near its 52-week high of $95.09, with a year-to-date increase of 17%. According to InvestingPro analysis, the stock appears overvalued at current levels, boasting a P/E ratio of 20.07. Following these sales, Knutson currently holds a total of 20,770 shares of Otter Tail Corp common stock, acquired through various means such as dividend reinvestment, the Employee Stock Purchase Plan, and restricted stock and performance share awards. The company has a commendable track record, with 56 consecutive years of dividend payments, currently yielding 2.49%. For those interested in a more in-depth analysis, a Pro Research Report on OTTR is available among over 1,400 US equities covered. Otter Tail Corp recently reported its second-quarter financial results, exceeding Wall Street expectations for both earnings and revenue. Adjusted diluted earnings per share stood at $1.66, surpassing the forecasted $1.51. Revenue for the quarter amounted to $334.38 million, surpassing the anticipated $326.12 million. This impressive performance was driven by record sales volumes in PVC pipes and consistent growth in the utility segment. However, the company faced a decline in profits compared to the previous year due to a significant antitrust settlement charge. Despite this setback, the earnings and revenue results remain positive developments for the company. These recent developments underscore the company's ability to excel in key areas despite financial challenges.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Oruka Therapeutics GC Paul Quinlan sells $5.64m stock",
        "url": "https://urgent.news/2026/08/15/oruka-therapeutics-gc-paul-quinlan-sells-5-64m-stock",
        "published": "2026-08-15T01:31:06.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}